Finance

Novo Integrated Sciences, a prominent player in the holistic healthcare industry, revealed today its decision to undergo a reverse stock split of its common stock

Dogness International Corporation, a prominent developer and manufacturer specializing in a wide range of pet products under the Dogness brand, as well as OEM and

Protalix BioTherapeutics, a leading biopharmaceutical company specializing in the development, production, and commercialization of recombinant therapeutic proteins through its proprietary ProCellEx® plant cell-based protein expression

TPI Composites, a leading manufacturer of wind blades, released its financial results for the third quarter (Q3) ending on September 30, 2023. The company’s stock,